CVR Medical Corp V.CVM.H

Alternate Symbol(s): CRRVF

Healthcare Medical Devices

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.

TSXV:CVM.H - Post by User

CVR Medical Corp

Bullboard Posts

Post by oldtimer42on Aug 07, 2019 12:08pm

120 Views

Post# 30002327

Waiting Game

Surely everyone realizes the implications of FDA approval. This is ground breaking technology, a real game changer. It will take time. Considering the impressive lineup of hospitals conducting clinical trials, the results of these trials are critical and the FDA will want to hear from all of them. No doubt CVM has been supplying the results to meet the FDA demands.

The issue of the trading halt is not that important right now. I suspect it is part of a strategy not to restart trading. If you look at the Board and management several have considerable investment experience. Just my feeling but the FDA approval announcement and trading resumption will be coordinated to maximize shareholder value.

just my thoughts. GLTA.

Bullboard Posts

Sony’s Alpha 1 II: A new professional photography standard?